Dare Bioscience, Inc. (DARE) Form 10-K Annual Reports
Dare Bioscience, Inc. (DARE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DARE
CIK: 1401914
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerWayne Pinnell
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEF 14A | 2026-10-06 | 2026-10-06 | DEF 14A | 0001493152-26-045977 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-09-28 | 8-K | 0001401914-26-000052 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-10-01 | 8-K | 0001493152-26-045275 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-23 | 2026-09-23 | PRE 14A | 0001493152-26-043921 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-10 | 8-K | 0001401914-26-000050 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001493152-26-041904 | View SEC Doc Filr Page |
| 424B3 | 2026-09-04 | — | 424B3 | 0001493152-26-041575 | View SEC Doc Filr Page |
| EFFECT | 2026-09-03 | — | EFFECT Filing | 9999999995-26-002882 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-28 | — | SCHEDULE 13G Filing | 0000929638-26-003281 | View SEC Doc Filr Page |
| S-1 | 2026-08-26 | — | S-1 | 0001493152-26-040265 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-24 | — | SCHEDULE 13G Filing | 0001079973-26-001171 | View SEC Doc Filr Page |
| D | 2026-08-20 | — | D Filing | 0001493152-26-039295 | View SEC Doc Filr Page |
| 253G2 | 2026-08-19 | — | 253G2 | 0001493152-26-039244 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-14 | 8-K | 0001493152-26-038649 | View SEC Doc Filr Page |
| 424B5 | 2026-08-17 | — | 424B5 | 0001493152-26-038646 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001493152-26-037737 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001401914-26-000043 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-24 | 8-K | 0001493152-26-034483 | View SEC Doc Filr Page |
| 253G2 | 2026-07-17 | — | 253G2 | 0001401914-26-000041 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-13 | 8-K | 0001401914-26-000040 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-13 | 8-K | 0001493152-26-032963 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001401914-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001401914-26-000036 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001401914-26-000035 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001401914-26-000034 | View SEC Doc Filr Page |